Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Bright Green Corp. (BGXX)
NASDAQ:BGXX
Bright Green Corp. (BGXX) Stock Price & Analysis
85 Followers
BGXX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.15 - $0.90
Previous Close$0.24
Volume150.30K
Average Volume (3M)1.72M
Market Cap
$45.62M
Enterprise Value$45.29M
Total Cash (Recent Filing)$0.00
Total Debt (Recent Filing)$166.24K
Price to Earnings (P/E)―
Beta1.18
Next Earnings
Aug 19, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.06
Shares Outstanding190,166,318
10 Day Avg. Volume774,531
30 Day Avg. Volume1,717,226
Standard Deviation0.29
R-Squared0.02
Alpha-0.08
Financial Highlights & Ratios
Price to Book (P/B)4.87
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)748.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-4.72
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Bright Green Corp. News
PremiumPress Releases
CEO UPDATE
PremiumCompany Announcements
Bright Green Corp. Enhances CEO’s Compensation and Incentives
PremiumCompany Announcements
Bright Green Corp Enhances Leadership and Governance
Ownership Overview
59.58% Insiders
2.33% Mutual Funds
1.20% Other Institutional Investors
36.89% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
BGXX FAQ
What was Bright Green Corp.’s price range in the past 12 months?
Bright Green Corp. lowest stock price was $0.15 and its highest was $0.90 in the past 12 months.
What is Bright Green Corp.’s market cap?
Currently, no data Available
When is Bright Green Corp.’s upcoming earnings report date?
Bright Green Corp.’s upcoming earnings report date is Aug 19, 2024 which is in 25 days.
How were Bright Green Corp.’s earnings last quarter?
Bright Green Corp. released its earnings results on May 22, 2024. The company reported -$0.005 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.005.
Is Bright Green Corp. overvalued?
According to Wall Street analysts Bright Green Corp.’s price is currently Overvalued.
Does Bright Green Corp. pay dividends?
Bright Green Corp. does not currently pay dividends.
What is Bright Green Corp.’s EPS estimate?
Bright Green Corp.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Bright Green Corp. have?
Bright Green Corp. has 190,166,320 shares outstanding.
What happened to Bright Green Corp.’s price movement after its last earnings report?
Bright Green Corp. reported an EPS of -$0.005 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 4.545%.
Which hedge fund is a major shareholder of Bright Green Corp.?
Currently, no hedge funds are holding shares in BGXX
---
Bright Green Corp. Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
BGXX Sentiment 100%
Sector Average 72%
Sector Average 72%
Insider Transactions
Sold Shares
Worth $350.0K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
-69.01%
12-Months-Change
Fundamentals
Return on Equity
-100.24%
Trailing 12-Months
Asset Growth
-33.98%
Trailing 12-Months
Company Description
Bright Green Corp.
Bright Green Corp is a provider of cannabis, cannabis-related products, and other legal medicinal plant-based therapies, manufactured for research and pharmaceutical applications, as well as being an active ingredient in consumer-based solutions. The company plans to focus on the development of cannabis strains and sales of products with high contents of CBN (cannabinol) and CBG (cannabigerol).
---
Technical Analysis
---